NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
H.R. 501, the Block, Report, and Suspend Suspicious Shipments Act; S. 2666, the E-Prescribing Parity for Controlled Substances Act Remote Prescribing of Controlled Substances
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KAITLIN KRELL | — |
| STEVEN W POSTAL New | — |
Medicare/Medicaid MMM
H.R. 1613 / S. 1038, the Drug Price Transparency in Medicaid Act; S. 2052, the Protect Patient Access to Pharmacies Act; H.R. 2880, the Protecting Patients Against PBM Abuses Act; H.R. 1770 / S. 2477, the Equitable Community Access to Pharmacist Services Act; S. 1491, the Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 2816, the PBM Sunshine and Accountability Act; H.R. 3281, the Transparent PRICE Act; H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act; H.R. 3561, the PATIENT Act; S. 1967, the Patients Before Middlemen (PBM) Act; S. 2129, the Ensuring Access to Lower-Cost Medicines for Seniors Act; S. 2405, the Strengthening Pharmacy Access for Seniors Act; S. 2973, the Modernizing and Ensuring PBM Accountability Act; H.R. 5378, the Lower Costs, More Transparency Act; H.R.5385, the Medicare PBM Accountability Act; H.R. 5393, to amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes; H.R. 5400 / S. 2436, the NO PBMs Act; S.3430,the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023; Request for Information Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program in the Inflation Reduction Act (IRA; P.L. 117-169)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KAITLIN KRELL | — |
| STEVEN W POSTAL New | — |
Pharmacy PHA
H.R. 167, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2023; H.R. 382, the Pandemic is Over Act; H.R. 2679, the Pharmacy Benefits Manager Accountability Act; H.R. 3008, the Drug Shortage Prevention Act; S. 1339, the Pharmacy Benefits Manager Reform Act; S. 1542 / H.R. 6283, the Delinking Revenue from Unfair Gouging Act; H.R. 5142, the Vaccine Injury Compensation Modernization Act of 2023; H.R. 5143, the Vaccine Access Improvement Act of 2023; S. 2305, the Biosimilar Red Tape Elimination Act; H.R. 1173, the Patients Right to Know Their Medication Act of 2023; Proposed rule for Medication Guides: Patient Medication Information (Docket No. FDA-2019-N-5959); Implementation of Public Law 113-54, the Drug Quality and Security Act; Draft Guidance for Industry, Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act, (Docket No. FDA-2015-D-3517); H.R. 5400 / S. 2436, the NO PBMs Act; S.3430,the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KAITLIN KRELL | — |
| STEVEN W POSTAL New | — |
Taxation/Internal Revenue Code TAX
S. 1108, the Death Tax Repeal Act; H.R. 4794, the Dietary Supplement Access Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KAITLIN KRELL | — |
Labor Issues/Antitrust/Workplace LBR
S. 127, the PBM Transparency Act; S. 113, the Prescription Pricing for the People Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KAITLIN KRELL | — |
| MATTHEW SEILER | — |
Defense DEF
TRICARE pharmacy network changes; H.R. 2670, the Military Construction Authorization Act for Fiscal Year 2024; H.R. 2670, National Defense Authorization Act for Fiscal Year 2024;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KAITLIN KRELL | — |
Budget/Appropriations BUD
FY24 appropriations language request to fund FTC enforcement of the Robinson-Patman Act; FY24 appropriations report language to address pharmacy compounding; FY24 appropriations report language to address TRICARE pharmacy network;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KAITLIN KRELL | — |
Small Business SMB
H.R.4035 / S. 2623, the Protecting Small Business Information Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE CASSITY | — |
| PHILLIP ADAM HARBISON | — |
| RONNA HAUSER | — |
| KAITLIN KRELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.